Justin Shenje

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova et al. · New England Journal of Medicine · 2021 · 551 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Thomas J. Scriba, Andrew Fioré-Gartland, Adam Penn‐Nicholson et al. · The Lancet Infectious Diseases · 2021 · 154 citations · Full text

Public Health, Community Health, Preventive Medicine +17

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

Michèle Tameris, Helen Mearns, Adam Penn‐Nicholson et al. · The Lancet Respiratory Medicine · 2019 · 137 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

Kelly E. Dooley, Susan L. Rosenkranz, Francesca Conradie et al. · The Lancet Infectious Diseases · 2021 · 124 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results

Jayne S. Sutherland, Gian van der Spuy, Awa Gindeh et al. · Clinical Infectious Diseases · 2021 · 113 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17